Additionally, two thyroid cancer cell lines (FTC 236 and 1736) were treated with 5-Aza-2'-deoxycytidine (Aza) and RASSF2 and RASSF5A expression was analyzed by qRT-PCR (Fig. 2B and 2C). This evidence concerns the gene RASSF2 and thyroid gland carcinoma.